Veterinary Medicines

Amoxy Active CTD 697 mg/g Powderfor Use in Drinking Water for Chickens, Turkeys and Ducks

Authorised
  • Amoxicillin trihydrate
Download as PDF

Product identification

Medicine name:
Amoxy Active CTD 697 mg/g Powderfor Use in Drinking Water for Chickens, Turkeys and Ducks
Amoxy Active CTD 800 mg/g Proszek do podania w wodzie do picia
Active substance:
  • Amoxicillin trihydrate
Target species:
  • Chicken
  • Turkey
  • Duck
Route of administration:
  • In drinking water use

Product details

Active substance and strength:
  • Amoxicillin trihydrate
    800.00
    milligram(s)
    /
    1.00
    gram(s)
Pharmaceutical form:
  • Powder for use in drinking water
Withdrawal period by route of administration:
  • In drinking water use
    • Chicken
      • Meat and offal
        1
        day
    • Turkey
      • Meat and offal
        5
        day
    • Duck
      • Meat and offal
        9
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01CA04
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Poland
Package description:
  • 250 g Securitainer: white cylindrical polypropylene container, covered with a low-density polyethylene closure.
  • 2,5 kg Bucket: white polypropylene square container provided with a polypropylene closure.
  • 500 g Securitainer: white cylindrical polypropylene container, covered with a low-density polyethylene closure.
  • 5 kg Bucket: white polypropylene square container provided with a polypropylene closure.
  • 100 g Securitainer: white cylindrical polypropylene container, covered with a low-density polyethylene closure.
  • 1 kg Securitainer: white cylindrical polypropylene container, covered with a low-density polyethylene closure.
  • 1 kg Bucket: white polypropylene square container provided with a polypropylene closure.

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Hybrid application (Article 13(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Dopharma Research B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Dopharma B.V.
Responsible authority:
  • Office For Registration Of Medicinal Products Medical Devices And Biocidal Products
Authorisation number:
  • 2881
Reference member state:
  • Netherlands
Procedure number:
  • NL/V/0308/001
Concerned member states:
  • France
  • Germany
  • Hungary
  • Italy
  • Lithuania
  • Poland
  • Romania
  • Spain
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Polish (PDF)
Published on: 4/02/2022
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Polish (PDF)
Published on: 4/02/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."